RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
EpicentRx, Inc.
Alliance for Clinical Trials in Oncology
SCRI Development Innovations, LLC
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center